METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
State Legislative Landscape in 2025 Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date
As a potent dual receptor agonist, this compound is extensively studied for its synergistic interaction with both the GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor pathways
By fixing the energy problem at the source, MOTS-c helps lower the systemic inflammatory burden
At our White Plains clinic, patients receive personalized support through services such as vitamin IV drips, NAD+, peptides, glutathione, immune-support injections, and vitamin B12 shots, all tailored to help you feel your best now while supporting long-term health